Evolus, Inc. (NASDAQ:EOLS) Q3 2021 Earnings Conference Call November 2, 2021 9:00 AM ET Company Representatives David Moatazedi - President, Chief Executive Officer Lauren Silvernail - Chief Financial Officer, Executive Vice President, Corporate Development Rui Avelar - Chief Medical Officer, Head of Research and Development David Erickson - Vice President of Investor Relations Conference Call Participants Louise Chen - Cantor Annabel Samimy - Stifel Marc Goodman - SVB Leerink Vamil Divan - Mizuho Securitie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _______ ...

Evolus, Inc. (NASDAQ:EOLS) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants David Erickson - VP, IR David Moatazedi - President and CEO Lauren Silvernail - CFO and EVP, Corporate Development Conference Call Participants Annabel Samimy - Stifel Rudy Li - SVB Leerink Carvey Leung - Cantor Fitzgerald Douglas Tsao - H.C. Wainwright Greg Fraser - Truist Securities Operator Greetings and welcome to the Evolus Second Quarter 2021 Earnings Call. At this time, all participants are in a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...

Evolus, Inc. (NASDAQ:EOLS) Q1 2021 Results Conference Call May 12, 2021 4:30 PM ET Company Participants Carol Ruth - The Ruth Group David Moatazedi - President and Chief Executive Officer Lauren Silvernail - Chief Financial Officer and EVP, Corporate Development Rui Avelar - Chief Medical Officer and Head of R&D Conference Call Participants Marc Goodman - SVB Leerink Annabel Samimy - Stifel Louise Chen - Cantor Greg Fraser - Truist Securities Douglas Chow - HCW Vamil Divan - Mizuho Securities Operator Good ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | her | --- | |-------------------| | | | OUR PURPOSE | | To make the | | beauty experience | | delightful and | | achievable | | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Evolus, Inc. (NASDAQ:EOLS) Q4 2020 Earnings Conference Call March 24, 2021 4:30 PM ET Company Participants Ashwin Agarwal – Vice President, Finance, Investor Relations and Treasurer David Moatazedi – President and Chief Executive Officer Lauren Silvernail – Chief Financial Officer and Executive Vice President, Corporate Development Conference Call Participants Marc Goodman – SVB Leerink Annabel Samimy – Stifel Louise Chen – Cantor Gregg Gilbert – Truist Securities Uy Ear – Mizuho Chris Bialas – H.C. Wainwri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________________ FORM 10-K _____________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38381 _____________________________ EVOLUS, INC. (Exact name of registrant as speci ...

| --- | --- | |-------|-------| | | | | | | | --- | |-------------------| | | | OUR PURPOSE | | To make the | | beauty experience | | delightful and | | achievable | her | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...